Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Tax Provisions (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Tax Provisions over the past 15 years, most recently at $33000.0 for Q2 2025.

  • Quarterly results put Tax Provisions at $33000.0 for Q2 2025, up 157.89% from a year ago — trailing twelve months through May 2025 was $43000.0 (down 76.5% YoY), and the annual figure for FY2025 was $43000.0, down 76.5%.
  • Tax Provisions for Q2 2025 was $33000.0 at Lifecore Biomedical, Inc. \De\, up from -$8000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for LFCR hit a ceiling of $3.4 million in Q1 2022 and a floor of -$15.8 million in Q2 2022.
  • Median Tax Provisions over the past 5 years was -$2000.0 (2022), compared with a mean of -$1.4 million.
  • Peak annual rise in Tax Provisions hit 2100.0% in 2023, while the deepest fall reached 1725.0% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Tax Provisions stood at -$6.3 million in 2021, then soared by 100.06% to $4000.0 in 2022, then crashed by 1725.0% to -$65000.0 in 2023, then soared by 166.15% to $43000.0 in 2024, then fell by 23.26% to $33000.0 in 2025.
  • The last three reported values for Tax Provisions were $33000.0 (Q2 2025), -$8000.0 (Q1 2025), and $43000.0 (Q4 2024) per Business Quant data.